mixed drug toxicity (25C-NBOMe and 4-fluoroamphetamine)
AI-generated summary
A 17-year-old male died from mixed drug toxicity involving 25C-NBOMe and 4-fluoroamphetamine after consuming a substance he believed was MDMA or psilocybin, obtained from unregulated drug markets. He experienced severe symptoms including seizures, agitation, metabolic acidosis, and hyperkalaemia requiring ICU admission with maximal vasopressor support and full medical resuscitation. Despite aggressive treatment including intubation, CPR, and intensive care, he died from profound hypoxic brain injury. The key clinical lesson is that unregulated drug markets present significant risks due to mislabelling and adulteration with dangerous novel psychoactive substances. This case was part of a cluster of five deaths with identical drug combinations. Prevention requires drug checking services and early warning networks to allow informed decision-making about substance consumption.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes.
ingestion of novel psychoactive substances mislabelled as MDMA
dangerous combination of 25C-NBOMe and 4-fluoroamphetamine
high potency of novel psychoactive substances
lack of drug checking services to identify substance composition
absence of early warning network to alert public
unregulated drug markets
cerebral oedema and global ischaemic cerebral injury
profound metabolic acidosis
critical hyperkalaemia
cardiac failure
Coroner's recommendations
That the Department of Health, as the appropriate arm of the Victorian Government, implements a drug checking service in the State of Victoria as a matter of urgency, to reduce the number of preventable deaths (and other lesser harms) associated with the use of drugs obtained from unregulated drug markets.
That the Department of Health, as the appropriate arm of the Victorian Government, implements a drug early warning network in the State of Victoria as a matter of urgency, to reduce the number of preventable deaths (and other lesser harms) associated with the use of drugs obtained from unregulated drug markets.
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. All court orders for redaction and non-publication are respected; documents with technically defective redaction have been excluded from the database entirely. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction —